Buffett built his company to last and carefully planned for his succession.
This continues to be a year of recovery for the U.S. manufacturing sector, with the Institute for Supply Management's ...
The record caps a long run. With reinvested dividends, the fund's return has averaged about 18% a year for the last decade. A ...
Viking Therapeutics raised $575 million to fund major obesity drug trials, develop its pipeline, and support commercial ...
Net interest margins are positioned for structural recovery as the interest rate environment turns and higher-yielding assets ...
Micron and other memory makers are well aware of the cyclical risk in the industry, and as such have been signing long-term ...
BioNTech announced that it was stopping a Phase 2 clinical trial for autogene cevumeran, which it was testing as an adjuvant ...
ServiceNow has pulled further ahead over the past two years, but Workday's growth remains steady — here's what the diverging ...
Analysts currently anticipate the company will earn $52.15 per share in fiscal 2031 (ending October). Place a 20-times ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results